151
151
Jun 6, 2015
06/15
by
KPIX
tv
eye 151
favorite 0
quote 0
and with me is patrick jane, a psychic who works with the fbi. this man. man: how would you describe him? i
and with me is patrick jane, a psychic who works with the fbi. this man. man: how would you describe him? i
134
134
Jun 6, 2015
06/15
by
WUSA
tv
eye 134
favorite 0
quote 0
and with me is patrick jane, a psychic who works with the fbi.g to help my colleagues understand this man. man: how would you describe him? i would say that he's obviously angry,
and with me is patrick jane, a psychic who works with the fbi.g to help my colleagues understand this man. man: how would you describe him? i would say that he's obviously angry,
119
119
tv
eye 119
favorite 0
quote 0
and with me is patrick jane, a psychic who works with the fbi.my colleagues understand this man. man: how would you describe him? i would say that he's obviously angry,
and with me is patrick jane, a psychic who works with the fbi.my colleagues understand this man. man: how would you describe him? i would say that he's obviously angry,
100
100
Jun 1, 2015
06/15
by
CNBC
tv
eye 100
favorite 0
quote 0
our own meg janes us now with with patrick. meg? >> reporter: kelly, thank you so much. thanks for joining us. tell us about the lung cancer drug. you have had some data coming out and some said that you were continue controversial about it. what was that about? >> we show data that showed a ten and a half month progression in those that did not have the meds. they're poor factor for people will lung cancer and showed an eight month and nearly 50 percent of patients that had brain that tas sis. when we can deliver this kind of data, it represents the treatments in a character four untreatable disease and treated with chemo and would deliver about three survival. >> tell us about the land of work nothing the same space. which one of you might get to masht first or does it matter? do you have to get to market first to win here? >> well we will probably arrive at the same time based on their statements and ours and the time line. i they we're going find out in the marketplace how each of us do. i am looking forward to being a strong competitor. >> kelly, you have a question
our own meg janes us now with with patrick. meg? >> reporter: kelly, thank you so much. thanks for joining us. tell us about the lung cancer drug. you have had some data coming out and some said that you were continue controversial about it. what was that about? >> we show data that showed a ten and a half month progression in those that did not have the meds. they're poor factor for people will lung cancer and showed an eight month and nearly 50 percent of patients that had brain...